
Oncolytics Biotech Inc
TSX:ONC

Fundamental Analysis


Revenue & Expenses Breakdown
Oncolytics Biotech Inc
Balance Sheet Decomposition
Oncolytics Biotech Inc
Current Assets | 18.5m |
Cash & Short-Term Investments | 16.5m |
Receivables | 89k |
Other Current Assets | 1.9m |
Non-Current Assets | 1.2m |
PP&E | 1.2m |
Free Cash Flow Analysis
Oncolytics Biotech Inc
CAD | |
Free Cash Flow | CAD |
Earnings Waterfall
Oncolytics Biotech Inc
Revenue
|
0
CAD
|
Operating Expenses
|
-33.3m
CAD
|
Operating Income
|
-33.3m
CAD
|
Other Expenses
|
1.8m
CAD
|
Net Income
|
-31.5m
CAD
|
ONC Profitability Score
Profitability Due Diligence
Oncolytics Biotech Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Score
Oncolytics Biotech Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
ONC Solvency Score
Solvency Due Diligence
Oncolytics Biotech Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Score
Oncolytics Biotech Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ONC Price Targets Summary
Oncolytics Biotech Inc
According to Wall Street analysts, the average 1-year price target for
ONC
is 4.67 CAD
with a low forecast of 3.54 CAD and a high forecast of 5.51 CAD.
Dividends
Current shareholder yield for ONC is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?